J&J Adds Two Drugs to 340B Contract Pharmacy Restrictions, Tells Providers to Self-Identify MFP Overpayments
Pharmaceutical giant Johnson & Johnson (J&J) recently updated its 340B contract pharmacy restrictions to add two new medications and extend [...]

